1Day Sooner
@1daysooner.bsky.social
1Day Sooner leads campaigns in science, policy, and bioethics to stop the world’s most harmful infectious diseases. We advocate for volunteers who participate in high-impact medical studies, including human challenge studies. www.1daysooner.org
The U.S. is sitting on a goldmine of health data. The data that exists could transform medicine and save lives. Right now it’s locked in silos across Medicare, Medicaid, VA & more.
It’s time to treat health data like public infrastructure.
🔗 city-journal.org/article/hhs-health-data-rfk
It’s time to treat health data like public infrastructure.
🔗 city-journal.org/article/hhs-health-data-rfk
October 29, 2025 at 6:38 PM
The U.S. is sitting on a goldmine of health data. The data that exists could transform medicine and save lives. Right now it’s locked in silos across Medicare, Medicaid, VA & more.
It’s time to treat health data like public infrastructure.
🔗 city-journal.org/article/hhs-health-data-rfk
It’s time to treat health data like public infrastructure.
🔗 city-journal.org/article/hhs-health-data-rfk
Tomorrow, we're joining global leaders, policymakers, scientists, and health experts as a featured speaker at the “Healthy #IndoorAir: A Global Call to Action” event, an official side event of #UNGA80. Watch it live at 3 p.m. EDT: bit.ly/4nfJbj5
September 22, 2025 at 2:37 PM
Tomorrow, we're joining global leaders, policymakers, scientists, and health experts as a featured speaker at the “Healthy #IndoorAir: A Global Call to Action” event, an official side event of #UNGA80. Watch it live at 3 p.m. EDT: bit.ly/4nfJbj5
We made water safe with filtration & disinfection. Now we can do the same for air with ventilation, filtration, and germicidal light, as illustrated in our latest @worksinprogress.bsky.social
piece. (1/10)
piece. (1/10)
September 19, 2025 at 7:41 PM
We made water safe with filtration & disinfection. Now we can do the same for air with ventilation, filtration, and germicidal light, as illustrated in our latest @worksinprogress.bsky.social
piece. (1/10)
piece. (1/10)
New Nature Reviews Immunology paper: "Targets of protective immunity & opportunities in hepatitis C virus vaccine development" explores the current landscape, including subunit, virus-like particle, viral vector, DNA & RNA vaccines, and controlled human infection models. Read at bit.ly/4md5EvH.
Targets of protective immunity and opportunities in hepatitis C virus vaccine development - Nature Reviews Immunology
Despite the advances in hepatitis C treatment, a prophylactic vaccine is still not available and will be needed to control and eliminate hepatitis C virus (HCV) infections globally. In this Review, th...
bit.ly
September 16, 2025 at 6:54 PM
New Nature Reviews Immunology paper: "Targets of protective immunity & opportunities in hepatitis C virus vaccine development" explores the current landscape, including subunit, virus-like particle, viral vector, DNA & RNA vaccines, and controlled human infection models. Read at bit.ly/4md5EvH.
We've launched the first-ever Cooperative Participant Organization (CPO) for clinical trials, connecting academic researchers with motivated healthy volunteers for crucial studies. Community trust + expertise from former participants = game-changing support for researchers.
bit.ly/4mlY3ey
bit.ly/4mlY3ey
Sept. 15, 2025: 1Day Sooner Launches Cooperative Participant Organization to Aid Clinical Trial Research - 1Day Sooner
1Day Sooner Launches Cooperative Participant Organization to Aid Clinical Trial Research Three world-renowned institutions join the program New York, NY–September […]
bit.ly
September 15, 2025 at 2:26 PM
We've launched the first-ever Cooperative Participant Organization (CPO) for clinical trials, connecting academic researchers with motivated healthy volunteers for crucial studies. Community trust + expertise from former participants = game-changing support for researchers.
bit.ly/4mlY3ey
bit.ly/4mlY3ey
Proud to have signed on to this act. Looking forward to seeing progress on indoor air quality!
Poor indoor air quality (IAQ) impacts kids and communities across our nation. Today, my colleague Brian Fitzpatrick and I introduced the bipartisan Indoor Air Quality and Healthy Schools Act to address this threat, improve IAQ nationwide, and protect public health.
Tonko, Fitzpatrick Introduce Bill to Improve Indoor Air Quality
tonko.house.gov
September 5, 2025 at 4:57 PM
Proud to have signed on to this act. Looking forward to seeing progress on indoor air quality!
We are hiring! If you are passionate about reducing the burden of infectious diseases worldwide, 1Day is seeking contractors to work on our African Medicines Agency engagement and using AI in the FDA projects. Apply today at www.1daysooner.org/jobs/.
August 29, 2025 at 3:29 PM
We are hiring! If you are passionate about reducing the burden of infectious diseases worldwide, 1Day is seeking contractors to work on our African Medicines Agency engagement and using AI in the FDA projects. Apply today at www.1daysooner.org/jobs/.
🚨 We're hiring a People Operations Lead! 🚨
🧠Own HR, onboarding, benefits, & culture.
🌎Remote-first international nonprofit.
🤝 High autonomy + direct access to leadership.
💼HR pros with 2+ yrs. of experience.
Apply by July 18. www.1daysooner.org/jobs/
🧠Own HR, onboarding, benefits, & culture.
🌎Remote-first international nonprofit.
🤝 High autonomy + direct access to leadership.
💼HR pros with 2+ yrs. of experience.
Apply by July 18. www.1daysooner.org/jobs/
June 24, 2025 at 1:50 PM
🚨 We're hiring a People Operations Lead! 🚨
🧠Own HR, onboarding, benefits, & culture.
🌎Remote-first international nonprofit.
🤝 High autonomy + direct access to leadership.
💼HR pros with 2+ yrs. of experience.
Apply by July 18. www.1daysooner.org/jobs/
🧠Own HR, onboarding, benefits, & culture.
🌎Remote-first international nonprofit.
🤝 High autonomy + direct access to leadership.
💼HR pros with 2+ yrs. of experience.
Apply by July 18. www.1daysooner.org/jobs/
Last chance to register for tomorrow's webinar! bit.ly/4le0yzu
Join us & @scientistsorg.bsky.social on 6/24 for a webinar on opportunities to integrate AI in the HHS. Experts will discuss implementation case studies, talent pathways like a proposed AI Corps, research opportunities, and public-private collaboration. Register today! bit.ly/4le0yzu
June 23, 2025 at 2:02 PM
Last chance to register for tomorrow's webinar! bit.ly/4le0yzu
Join us & @scientistsorg.bsky.social on 6/24 for a webinar on opportunities to integrate AI in the HHS. Experts will discuss implementation case studies, talent pathways like a proposed AI Corps, research opportunities, and public-private collaboration. Register today! bit.ly/4le0yzu
June 17, 2025 at 5:57 PM
Join us & @scientistsorg.bsky.social on 6/24 for a webinar on opportunities to integrate AI in the HHS. Experts will discuss implementation case studies, talent pathways like a proposed AI Corps, research opportunities, and public-private collaboration. Register today! bit.ly/4le0yzu
Join us in D.C. for a happy hour on fair compensation in clinical trials! Meet the authors of the new American Journal of Bioethics open letter on ethical pay for participants & connect with changemakers over drinks. Register today: bit.ly/4e5yHz2
June 16, 2025 at 2:28 PM
Join us in D.C. for a happy hour on fair compensation in clinical trials! Meet the authors of the new American Journal of Bioethics open letter on ethical pay for participants & connect with changemakers over drinks. Register today: bit.ly/4e5yHz2
ICYMI: 64 experts have published an open letter in The American Journal of Bioethics, calling for a reexamination of entrenched attitudes toward payment for clinical research participation.
bit.ly/4kWd06R
bit.ly/4kWd06R
New open letter in The American Journal of Bioethics challenges norms on paying research participants – 1Day Sooner
www.1daysooner.org
June 4, 2025 at 4:32 PM
ICYMI: 64 experts have published an open letter in The American Journal of Bioethics, calling for a reexamination of entrenched attitudes toward payment for clinical research participation.
bit.ly/4kWd06R
bit.ly/4kWd06R
Check out our latest news in our May newsletter: mailchi.mp/1daysooner.o....
May 30, 2025 at 7:03 PM
Check out our latest news in our May newsletter: mailchi.mp/1daysooner.o....
As the FDA faces significant staffing reductions, there could be ripple effects for US companies & leadership in the biomedical space, as well as for other countries that depend on FDA's leadership to enable access to key health tools. @ghtcoalition.org bit.ly/3T0S1U8
Ripple effects: How U.S. FDA layoffs threaten global health in low- and middle-income countries and weaken US competitiveness – 1Day Sooner
bit.ly
May 28, 2025 at 1:58 PM
As the FDA faces significant staffing reductions, there could be ripple effects for US companies & leadership in the biomedical space, as well as for other countries that depend on FDA's leadership to enable access to key health tools. @ghtcoalition.org bit.ly/3T0S1U8
Why are we so afraid to fairly compensate research participants?
64 experts challenge the idea that payment = undue influence.
Read our open letter in The American Journal of Bioethics highlighting the pitfalls of excessive concern over payment to research participants. bit.ly/43vpdbo
64 experts challenge the idea that payment = undue influence.
Read our open letter in The American Journal of Bioethics highlighting the pitfalls of excessive concern over payment to research participants. bit.ly/43vpdbo
Pursuing Fair and Just Compensation for Research Participants: An Open Letter to the Research Ethics Community
Published in The American Journal of Bioethics (Ahead of Print, 2025)
bit.ly
May 27, 2025 at 6:29 PM
Why are we so afraid to fairly compensate research participants?
64 experts challenge the idea that payment = undue influence.
Read our open letter in The American Journal of Bioethics highlighting the pitfalls of excessive concern over payment to research participants. bit.ly/43vpdbo
64 experts challenge the idea that payment = undue influence.
Read our open letter in The American Journal of Bioethics highlighting the pitfalls of excessive concern over payment to research participants. bit.ly/43vpdbo
On #ClinicalTrialsDay, we thank the volunteers who have stepped forward to participate in human challenge studies. Your selflessness and commitment to advancing science have played a vital role in improving public health.
Sign up to learn more on how to participate: www.1daysooner.org/volunteer/.
Sign up to learn more on how to participate: www.1daysooner.org/volunteer/.
May 20, 2025 at 3:55 PM
On #ClinicalTrialsDay, we thank the volunteers who have stepped forward to participate in human challenge studies. Your selflessness and commitment to advancing science have played a vital role in improving public health.
Sign up to learn more on how to participate: www.1daysooner.org/volunteer/.
Sign up to learn more on how to participate: www.1daysooner.org/volunteer/.
Bipartisan momentum for U.S. biotech: The National Biotechnology Initiative Act of 2025 would create a White House-led office to coordinate federal biotech strategy across security, economy & innovation. www.biotech.senate.gov/press-releas...
National Security Commission on Emerging Biotechnology Congressional Commissioners Introduce Bill to Promote U.S. Biotechnology Innovation - Biotech
National Security Commission on Emerging Biotechnology Congressional Commissioners Introduce Bill to Promote U.S. Biotechnology Innovation Bipartisan legislation promotes federal coordination and s...
www.biotech.senate.gov
May 1, 2025 at 3:33 PM
Bipartisan momentum for U.S. biotech: The National Biotechnology Initiative Act of 2025 would create a White House-led office to coordinate federal biotech strategy across security, economy & innovation. www.biotech.senate.gov/press-releas...
Policymakers from 11 African countries met for #COPEMA's first regional summit to fight malaria. We are proud to see our cost analysis shared by another presenter and to have 1Day Africa's Zach Kauko share our work! Read our cost analysis here: www.1daysooner.org/cost-effecti....
April 30, 2025 at 1:41 PM
Policymakers from 11 African countries met for #COPEMA's first regional summit to fight malaria. We are proud to see our cost analysis shared by another presenter and to have 1Day Africa's Zach Kauko share our work! Read our cost analysis here: www.1daysooner.org/cost-effecti....
On #WorldMalariaDay, we’re reminded that access & vaccine costs can mean life or death.
🦟 Malaria caused 249M cases & 608K deaths in 2022 alone. It’s time to embrace this year's theme: "reinvest, reimagine, reignite." 1Day Africa’s Dir spoke with The Economist on bridging this gap. bit.ly/4cPGeBs
🦟 Malaria caused 249M cases & 608K deaths in 2022 alone. It’s time to embrace this year's theme: "reinvest, reimagine, reignite." 1Day Africa’s Dir spoke with The Economist on bridging this gap. bit.ly/4cPGeBs
A faster rollout of malaria vaccines would save many lives
But someone needs to pay for it—just when aid budgets are being slashed
bit.ly
April 25, 2025 at 1:57 PM
On #WorldMalariaDay, we’re reminded that access & vaccine costs can mean life or death.
🦟 Malaria caused 249M cases & 608K deaths in 2022 alone. It’s time to embrace this year's theme: "reinvest, reimagine, reignite." 1Day Africa’s Dir spoke with The Economist on bridging this gap. bit.ly/4cPGeBs
🦟 Malaria caused 249M cases & 608K deaths in 2022 alone. It’s time to embrace this year's theme: "reinvest, reimagine, reignite." 1Day Africa’s Dir spoke with The Economist on bridging this gap. bit.ly/4cPGeBs
📣April newsletter drop! Check out our latest and greatest: bit.ly/3Yeo86a.
April 24, 2025 at 5:53 PM
📣April newsletter drop! Check out our latest and greatest: bit.ly/3Yeo86a.
New study in Vaccine says COVID human challenge trials (HCTs) aren’t “too risky”—they may be low or even minimal risk for eligible volunteers. Time to reassess how we evaluate HCTs in pandemics. bit.ly/3YeLngi
Assessing the risks of current COVID-19 challenge trials systematically
A large international collaboration has started a series of SARS-CoV-2 (COVID) human challenge trials (HCTs). However, critics of previously proposed …
bit.ly
April 23, 2025 at 7:19 PM
New study in Vaccine says COVID human challenge trials (HCTs) aren’t “too risky”—they may be low or even minimal risk for eligible volunteers. Time to reassess how we evaluate HCTs in pandemics. bit.ly/3YeLngi
ICYMI, our latest webinar, "Volunteering in Controlled Human Infection Model Studies," features a panel of experts answering all your burning questions about participating in a human challenge trial. Watch at bit.ly/4igtDrT.
Volunteering in Controlled Human Infection Model (CHIM) Studies Webinar
In this webinar, you'll learn about how to volunteer for controlled human infection model studies, otherwise known as human challenge studies, where healthy, adult participants volunteer to be exposed to a disease to find or test new treatments. Our panelists discussed: -How to get involved and determine if it's right for you -Provided an overview of the most commonly researched diseases -Debated current compensation levels and other bioethical issues
bit.ly
April 18, 2025 at 1:56 PM
ICYMI, our latest webinar, "Volunteering in Controlled Human Infection Model Studies," features a panel of experts answering all your burning questions about participating in a human challenge trial. Watch at bit.ly/4igtDrT.
We are hiring a Volunteer Coordinator for our Cooperative Participant Organization. We are seeking a person
✔️ Passionate about advocating for clinical trial participants
✔️ Skilled in executing targeted outreach strategies
✔️ Ideally located in Europe or the United Kingdom
Apply today: bit.ly/4cAwBGp
✔️ Passionate about advocating for clinical trial participants
✔️ Skilled in executing targeted outreach strategies
✔️ Ideally located in Europe or the United Kingdom
Apply today: bit.ly/4cAwBGp
April 16, 2025 at 6:01 PM
We are hiring a Volunteer Coordinator for our Cooperative Participant Organization. We are seeking a person
✔️ Passionate about advocating for clinical trial participants
✔️ Skilled in executing targeted outreach strategies
✔️ Ideally located in Europe or the United Kingdom
Apply today: bit.ly/4cAwBGp
✔️ Passionate about advocating for clinical trial participants
✔️ Skilled in executing targeted outreach strategies
✔️ Ideally located in Europe or the United Kingdom
Apply today: bit.ly/4cAwBGp
Our full response to the U.S. government's RFI on AI and public health is now public!
We dig into how AI can help us speed up biomedical research and be a tool for good.
Read it here: bit.ly/42cU0dG
We dig into how AI can help us speed up biomedical research and be a tool for good.
Read it here: bit.ly/42cU0dG
April 15, 2025 at 2:35 PM
Our full response to the U.S. government's RFI on AI and public health is now public!
We dig into how AI can help us speed up biomedical research and be a tool for good.
Read it here: bit.ly/42cU0dG
We dig into how AI can help us speed up biomedical research and be a tool for good.
Read it here: bit.ly/42cU0dG
Reposted by 1Day Sooner
💥 A blinded #StrepA human challenge PK/PD RCT 💥
All-star collaboration between @thekidsau.bsky.social & #MCRI & #UWA.
@hicvac.bsky.social @1daysooner.bsky.social
Thanks @onisillos.bsky.social @lancetmicrobe.bsky.social for support of human challenge research!
www.thelancet.com/journals/lan...
All-star collaboration between @thekidsau.bsky.social & #MCRI & #UWA.
@hicvac.bsky.social @1daysooner.bsky.social
Thanks @onisillos.bsky.social @lancetmicrobe.bsky.social for support of human challenge research!
www.thelancet.com/journals/lan...
Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial
When steady-state penicillin concentrations are greater than 9 ng/mL, few people will
develop experimental emm75 S pyogenes pharyngitis. These data will inform efforts
to improve long-acting penicilli...
www.thelancet.com
March 26, 2025 at 8:38 PM
💥 A blinded #StrepA human challenge PK/PD RCT 💥
All-star collaboration between @thekidsau.bsky.social & #MCRI & #UWA.
@hicvac.bsky.social @1daysooner.bsky.social
Thanks @onisillos.bsky.social @lancetmicrobe.bsky.social for support of human challenge research!
www.thelancet.com/journals/lan...
All-star collaboration between @thekidsau.bsky.social & #MCRI & #UWA.
@hicvac.bsky.social @1daysooner.bsky.social
Thanks @onisillos.bsky.social @lancetmicrobe.bsky.social for support of human challenge research!
www.thelancet.com/journals/lan...